Jiahui Lai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jiahui Lai has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Xun Liu
Department of Nephrology Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong China
2 shared publications Cailian Cheng
Department of Nephrology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510635, Guangdong, China
1 shared publication- Chun-Fang Xie
Department of Chemical Engineering, School of Chemistry and Chemical Engineering, Nanchang University, Nanchang 330031, China
1 shared publication Cong-Bo Huang
Department of Chemical Engineering, School of Chemistry and Chemical Engineering, Nanchang University, Nanchang 330031, China
1 shared publication- Dongfang Zhou
Southern Medical University
1 shared publication - Hailong Peng
School of Chemistry and Chemical Engineering, Nanchang University, Nanchang 330031, China
1 shared publication
Latest Publications
- Open Access
- 15 August 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 921
Development and multi-cohort validation of a machine learning-based simplified frailty assessment tool for clinical risk prediction
Background: Frailty significantly impacts health outcomes in aging populations, yet its routine assessment remains challenging due to the complexity and time-consuming nature of existing tools. This study aimed to develop and validate a clinically feasible, machine learning-based frailty assessment tool that balances predictive accuracy with implementation simplicity in real-world clinical settings. Methods: We conducted a multi-cohort study leveraging data from the National Health and Nutrition Examination Survey (NHANES, n = 3,480), China Health and Retirement Longitudinal Study (CHARLS, n = 16,792), China Health and Nutrition Survey (CHNS, n = 6,035), and Sun Yat-sen University Third Affiliated Hospital CKD cohort (SYSU3 CKD, n = 2,264). Through systematic application of five complementary feature selection algorithms to 75 potential variables, followed by comparative evaluation of 12 machine learning approaches, we developed a parsimonious assessment tool for predicting frailty diagnosis, chronic kidney disease progression, cardiovascular events, and all-cause mortality. Results: Our analysis identified a minimal set of just eight readily available clinical parameters— age, sex, body mass index (BMI), pulse pressure, creatinine, hemoglobin, and preparing meals difficulty and lifting/carrying difficulty—that demonstrated robust predictive power. The extreme gradient boosting (XGBoost) algorithm exhibited superior performance across training (AUC 0.963, 95% CI: 0.951–0.975), internal validation (AUC 0.940, 95% CI: 0.924–0.956), and external validation (AUC 0.850, 95% CI: 0.832–0.868) datasets. This model significantly outperformed traditional frailty indices in predicting CKD progression (AUC 0.916 vs. 0.701, p < 0.001), cardiovascular events (AUC 0.789 vs. 0.708, p < 0.001), and mortality (time-dependent AUC 0.767 − 0.702 vs. 0.690 − 0.627, p < 0.001). SHAP analysis provided transparent insights into model predictions, facilitating clinical interpretation. Conclusion: Our simplified frailty assessment tool demonstrates robust performance across multiple health outcomes while minimizing measurement burden. The model’s superior predictive capabilities for CKD progression, cardiovascular events, and mortality underscore its potential utility for risk stratification.
- 15 August 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 921
Open AccessDevelopment and multi-cohort validation of a machine learning-based simplified frailty assessment tool for clinical risk prediction
Background: Frailty significantly impacts health outcomes in aging populations, yet its routine assessment remains challenging due to the complexity and time-consuming nature of existing tools. This study aimed to develop and validate a clinically feasible, machine learning-based frailty assessment tool that balances predictive accuracy with implementation simplicity in real-world clinical settings. Methods: We conducted a multi-cohort study leveraging data from the National Health and Nutrition Examination Survey (NHANES, n = 3,480), China Health and Retirement Longitudinal Study (CHARLS, n = 16,792), China Health and Nutrition Survey (CHNS, n = 6,035), and Sun Yat-sen University Third Affiliated Hospital CKD cohort (SYSU3 CKD, n = 2,264). Through systematic application of five complementary feature selection algorithms to 75 potential variables, followed by comparative evaluation of 12 machine learning approaches, we developed a parsimonious assessment tool for predicting frailty diagnosis, chronic kidney disease progression, cardiovascular events, and all-cause mortality. Results: Our analysis identified a minimal set of just eight readily available clinical parameters— age, sex, body mass index (BMI), pulse pressure, creatinine, hemoglobin, and preparing meals difficulty and lifting/carrying difficulty—that demonstrated robust predictive power. The extreme gradient boosting (XGBoost) algorithm exhibited superior performance across training (AUC 0.963, 95% CI: 0.951–0.975), internal validation (AUC 0.940, 95% CI: 0.924–0.956), and external validation (AUC 0.850, 95% CI: 0.832–0.868) datasets. This model significantly outperformed traditional frailty indices in predicting CKD progression (AUC 0.916 vs. 0.701, p < 0.001), cardiovascular events (AUC 0.789 vs. 0.708, p < 0.001), and mortality (time-dependent AUC 0.767 − 0.702 vs. 0.690 − 0.627, p < 0.001). SHAP analysis provided transparent insights into model predictions, facilitating clinical interpretation. Conclusion: Our simplified frailty assessment tool demonstrates robust performance across multiple health outcomes while minimizing measurement burden. The model’s superior predictive capabilities for CKD progression, cardiovascular events, and mortality underscore its potential utility for risk stratification.
- 18 January 2025
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 217, 115516
Intra-tumoral bacteria in breast cancer and intervention strategies
- 18 January 2025
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 217, 115516
Intra-tumoral bacteria in breast cancer and intervention strategies
- Open Access
- 1 November 2023
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 5273-5285
Predictive Effect of System Inflammation Response Index for Progression of Chronic Kidney Disease in Non-Dialyzing Patient
Purpose: Scant research has been conducted on the interplay between the systemic inflammation response index (SIRI) and chronic kidney disease (CKD). The present study endeavors to meticulously scrutinize the association between SIRI and renal function. Additionally, we aim to assess its efficacy in predicting the progression of CKD in non-dialysis patients. Patients and Methods: Adult patients with CKD who were not undergoing dialysis were enrolled, and follow-up data were obtained. Data from distinct groups were extracted and meticulously compared. A comprehensive analytical approach was adopted, including logistic regression analysis, Kaplan-Meier analysis, Cox proportional hazards regression analysis, and subgroup analysis. Results: Our study included 1420 patients, with a mean age of 61 ± 17 years, and 63% were male. 244 (17.2%) patients experienced the progression of CKD. As the level of ln(SIRI) increased, patients tended to be older, with a higher proportion of males, and increased prevalence rates of hypertension, stroke, heart failure, and progression of CKD. Additionally, the levels of baseline creatinine and C-reactive protein were elevated, while the levels of estimated glomerular filtration rate and hemoglobin decreased. Upon adjusting for demographic and biochemical variables, logistic regression analysis indicated that ln(SIRI) was independently associated with advanced CKD in pre-dialysis patients (OR=1.59, 95% CI: 1.29– 1.95, P< 0.001). Moreover, Cox proportional-hazard analysis revealed that ln(SIRI) independently predicted CKD progression (HR: 1.3, 95% CI: 1.07– 1.59, P=0.009). Conducting a subgroup analysis, we observed significant interactions between ln(SIRI) levels and gender (p< 0.001), age (p=0.046), and hypertension (p=0.028) in relation to the progression of CKD. Conclusion: Our study’s findings demonstrate a significant association between SIRI and fundamental renal function, and independently establish a correlation between SIRI and the progression of CKD in pre-dialysis patients. These observations suggest that SIRI holds promise as a potential predictor for CKD progression.
- 1 November 2023
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 5273-5285
Open AccessPredictive Effect of System Inflammation Response Index for Progression of Chronic Kidney Disease in Non-Dialyzing Patient
Purpose: Scant research has been conducted on the interplay between the systemic inflammation response index (SIRI) and chronic kidney disease (CKD). The present study endeavors to meticulously scrutinize the association between SIRI and renal function. Additionally, we aim to assess its efficacy in predicting the progression of CKD in non-dialysis patients. Patients and Methods: Adult patients with CKD who were not undergoing dialysis were enrolled, and follow-up data were obtained. Data from distinct groups were extracted and meticulously compared. A comprehensive analytical approach was adopted, including logistic regression analysis, Kaplan-Meier analysis, Cox proportional hazards regression analysis, and subgroup analysis. Results: Our study included 1420 patients, with a mean age of 61 ± 17 years, and 63% were male. 244 (17.2%) patients experienced the progression of CKD. As the level of ln(SIRI) increased, patients tended to be older, with a higher proportion of males, and increased prevalence rates of hypertension, stroke, heart failure, and progression of CKD. Additionally, the levels of baseline creatinine and C-reactive protein were elevated, while the levels of estimated glomerular filtration rate and hemoglobin decreased. Upon adjusting for demographic and biochemical variables, logistic regression analysis indicated that ln(SIRI) was independently associated with advanced CKD in pre-dialysis patients (OR=1.59, 95% CI: 1.29– 1.95, P< 0.001). Moreover, Cox proportional-hazard analysis revealed that ln(SIRI) independently predicted CKD progression (HR: 1.3, 95% CI: 1.07– 1.59, P=0.009). Conducting a subgroup analysis, we observed significant interactions between ln(SIRI) levels and gender (p< 0.001), age (p=0.046), and hypertension (p=0.028) in relation to the progression of CKD. Conclusion: Our study’s findings demonstrate a significant association between SIRI and fundamental renal function, and independently establish a correlation between SIRI and the progression of CKD in pre-dialysis patients. These observations suggest that SIRI holds promise as a potential predictor for CKD progression.
- 4 September 2023
- Published by Elsevier in Separation and Purification Technology
- Vol. 328, 124999
Synthesis of a gelatin based molecularly imprinted hydrogel with high selectivity on adsorbing bovine serum albumin
- 4 September 2023
- Published by Elsevier in Separation and Purification Technology
- Vol. 328, 124999
Synthesis of a gelatin based molecularly imprinted hydrogel with high selectivity on adsorbing bovine serum albumin
- 1 October 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 26, 3122-3125
Research on stepper motor motion control based on MCU
In this paper, speed control curve of stepper motor was studied for optimizing the motion flexibility and improving the motion precision of the stepper motor under the open-loop control environment based on Microcontroller Unit (MCU). Firstly, the acceleration and deceleration control curve of trapezoidal and New S model was designed respectively. Secondly, the relationship curve between control pulse and time was discretized and the stepper motor control scheme was determined. The MCU provided drive pulse for stepper motor to realize the motion control. The contrast of running accuracy of stepper motor controlled by the two kinds of acceleration and deceleration curves was carried out. The results show that the stepper motor controlled by the new S-shape acceleration and deceleration curve has great performs of small noise, high positioning accuracy and good flexibility.
- 1 October 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 26, 3122-3125
Research on stepper motor motion control based on MCU
In this paper, speed control curve of stepper motor was studied for optimizing the motion flexibility and improving the motion precision of the stepper motor under the open-loop control environment based on Microcontroller Unit (MCU). Firstly, the acceleration and deceleration control curve of trapezoidal and New S model was designed respectively. Secondly, the relationship curve between control pulse and time was discretized and the stepper motor control scheme was determined. The MCU provided drive pulse for stepper motor to realize the motion control. The contrast of running accuracy of stepper motor controlled by the two kinds of acceleration and deceleration curves was carried out. The results show that the stepper motor controlled by the new S-shape acceleration and deceleration curve has great performs of small noise, high positioning accuracy and good flexibility.